Recap: Travere Therapeutics Q3 Earnings

Travere Therapeutics (NASDAQ:TVTX) reported its Q3 earnings results on Thursday, October 27, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Travere Therapeutics beat estimated earnings by 14.61%, reporting an EPS of $-0.76 versus an estimate of $-0.89.

Revenue was down $14.72 million from the same period last year.

Last quarter the company beat on EPS by $0.23 which was followed by a 7.91% increase in the share price the next day.

Here's a look at Travere Therapeutics's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	-0.88	-0.85	-0.72	-0.54
EPS Actual	-0.65	-0.82	-0.61	-0.13
Revenue Estimate	49.63M	51.92M	57.81M	60.93M
Revenue Actual	54.17M	48.49M	57.25M	68.22M

To track all earnings releases for Travere Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.